[{"address1": "103 Carnegie Center Drive", "address2": "Suite 309", "city": "Princeton", "state": "NJ", "zip": "08540", "country": "United States", "phone": "609 486 2308", "website": "https://www.lianbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with preserved ejection fraction; TP-03 for the treatment of Demodex blepharitis and meibomian gland disease; NBTXR3 for the treatment of head and neck squamous cell carcinoma, and solid tumor; Infigratinib for the treatment of second-line and first-line cholangiocarcinoma, and gastric cancers; BBP-398 for solid tumors; Omilancor and NX-13 for ulcerative colitis and Crohn's disease; LYR-210 for chronic rhinosinusitis; and Sisunatovir for respiratory syncytical virus. It has a partnership with Tarsus Pharmaceuticals, Inc. to develop and commercialize TP-03 for the treatment of Demodex blepharitis; and Nanobiotix S.A. to develop and commercialize NBTXR3, a radioenhancer designed to be injected directly into a malignant tumor prior to standard radiotherapy. The company was incorporated in 2019 and is headquartered in Princeton, New Jersey.", "fullTimeEmployees": 163, "companyOfficers": [{"maxAge": 1, "name": "Mr. Konstantin  Poukalov", "age": 39, "title": "Founder & Executive Chairman", "yearBorn": 1984, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Adam Leo Stone", "age": 42, "title": "Interim CEO & Director", "yearBorn": 1981, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Ehong  Gu", "title": "Interim CFO, VP & Head of Global Finance", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ji  Chen", "title": "Senior VP & General Counsel", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Brianne  Jahn", "age": 37, "title": "Chief Business Officer", "yearBorn": 1986, "fiscalYear": 2020, "totalPay": 697467, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael  Humphries M.D.", "title": "Chief Scientific Advisor", "fiscalYear": 2020, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Levvy Lv D. Eng", "title": "Senior VP & Global Head of Development", "fiscalYear": 2020, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1609372800, "maxAge": 86400, "priceHint": 4, "previousClose": 4.92, "open": 4.89, "dayLow": 4.89, "dayHigh": 4.935, "regularMarketPreviousClose": 4.92, "regularMarketOpen": 4.89, "regularMarketDayLow": 4.89, "regularMarketDayHigh": 4.935, "exDividendDate": 1710460800, "beta": 0.232, "forwardPE": -5.805882, "volume": 109576, "regularMarketVolume": 109576, "averageVolume": 541963, "averageVolume10days": 705220, "averageDailyVolume10Day": 705220, "bid": 4.89, "ask": 4.9, "bidSize": 2200, "askSize": 1100, "marketCap": 533290912, "fiftyTwoWeekLow": 1.33, "fiftyTwoWeekHigh": 4.935, "fiftyDayAverage": 4.3958, "twoHundredDayAverage": 3.02007, "currency": "USD", "enterpriseValue": 316063168, "floatShares": 25383914, "sharesOutstanding": 108063000, "sharesShort": 568791, "sharesShortPriorMonth": 1796440, "sharesShortPreviousMonthDate": 1705017600, "dateShortInterest": 1707955200, "sharesPercentSharesOut": 0.0053, "heldPercentInsiders": 0.059070002, "heldPercentInstitutions": 0.78994006, "shortRatio": 0.9, "shortPercentOfFloat": 0.0125, "impliedSharesOutstanding": 108063000, "bookValue": 1.888, "priceToBook": 2.613877, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -87981000, "trailingEps": -0.82, "forwardEps": -0.85, "pegRatio": 0.2, "enterpriseToEbitda": -3.003, "52WeekChange": 1.6885245, "SandP52WeekChange": 0.27220368, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "LIAN", "underlyingSymbol": "LIAN", "shortName": "LianBio", "longName": "LianBio", "firstTradeDateEpochUtc": 1635773400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "f81cec73-1f77-34c7-bba7-e7e32beb34f1", "messageBoardId": "finmb_695075138", "gmtOffSetMilliseconds": -18000000, "currentPrice": 4.935, "targetHighPrice": 4.8, "targetLowPrice": 3.0, "targetMeanPrice": 3.9, "targetMedianPrice": 3.9, "recommendationMean": 3.0, "recommendationKey": "hold", "numberOfAnalystOpinions": 2, "totalCash": 252222000, "totalCashPerShare": 2.334, "ebitda": -105259000, "totalDebt": 2843000, "quickRatio": 9.913, "currentRatio": 10.06, "debtToEquity": 1.204, "returnOnAssets": -0.21666999, "returnOnEquity": -0.32423002, "freeCashflow": -36857376, "operatingCashflow": -83527000, "financialCurrency": "USD", "trailingPegRatio": null}]